Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Detalhes bibliográficos
Main Authors:	Kehoe, P, Williams, J, Lovestone, S, Wilcock, G, Owen, M
Formato:	Journal article
Idioma:	English
Publicado em:	1996

Registos relacionados

Presenilin-1 polymorphism and Alzheimer's disease [6]
Por: Kehoe, P, et al.
Publicado em: (1996)

The Presenilins and Alzheimer Disease
Por: G. Lévesque, et al.
Publicado em: (2020-12-01)

Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease.
Por: Tysoe, C, et al.
Publicado em: (1997)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
Por: Kehoe, P, et al.
Publicado em: (1996)

Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium.
Por: Lovestone, S, et al.
Publicado em: (1996)

Presenilins in Alzheimer’s disease and frontotemporal dementia
Por: Shen Jie
Publicado em: (2012-02-01)

Presenilin mutations and their impact on neuronal differentiation in Alzheimer’s disease
Por: Mercedes A Hernandez-Sapiens, et al.
Publicado em: (2022-01-01)

A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.
Por: Tysoe, C, et al.
Publicado em: (1998)

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
Por: Kehoe, P, et al.
Publicado em: (1998)

Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK.
Por: Dow, D, et al.
Publicado em: (1999)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
Por: Chalmers, K, et al.
Publicado em: (2004)

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
Por: Wilcock, G
Publicado em: (1994)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
Por: Culpan, D, et al.
Publicado em: (2003)

Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.
Por: Irving, N, et al.
Publicado em: (1997)

Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling
Por: Mario Nizzari, et al.
Publicado em: (2012-01-01)

Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice
Por: Anne Eckert, et al.
Publicado em: (2001-04-01)

Switched Aβ43 generation in familial Alzheimer’s disease with presenilin 1 mutation
Por: Nobuto Kakuda, et al.
Publicado em: (2021-11-01)

No observed effect on brain vasculature of Alzheimer’s disease-related mutations in the zebrafish presenilin 1 gene
Por: Karissa Barthelson, et al.
Publicado em: (2021-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Por: Kehoe, P, et al.
Publicado em: (2007)

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
Por: Kehoe, P, et al.
Publicado em: (1999)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
Por: Chalmers, K, et al.
Publicado em: (2004)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
Por: Culpan, D, et al.
Publicado em: (2007)

Presenilin-1-Derived Circular RNAs: Neglected Epigenetic Regulators with Various Functions in Alzheimer’s Disease
Por: Nima Sanadgol, et al.
Publicado em: (2023-09-01)

Protein Predictive Modeling and Simulation of Mutations of Presenilin-1 Familial Alzheimer’s Disease on the Orthosteric Site
Por: Alejandro Soto-Ospina, et al.
Publicado em: (2021-06-01)

Association of interleukin-1 gene polymorphisms with Alzheimer's disease.
Por: Nicoll, J, et al.
Publicado em: (2000)

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
Por: Ayako Suzuki, et al.
Publicado em: (2016-03-01)

Treating Alzheimer's disease.
Por: Wilcock, G, et al.
Publicado em: (1995)

Neurotrophins in Alzheimer's disease
Por: Wilcock, G
Publicado em: (2002)

Treatment for Alzheimer's disease.
Por: Wilcock, G
Publicado em: (2000)

Changes in the expression of the Alzheimer's disease-associated presenilin gene in drosophila heart leads to cardiac dysfunction
Por: Li, A., et al.
Publicado em: (2012)

Velnacrine for Alzheimer's disease.
Por: Birks, J, et al.
Publicado em: (2004)

Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee.
Por: Wilcock, G, et al.
Publicado em: (1989)

Alzheimer's Disease Associated Presenilin 1 Interacts with HC5 and ZETA, Subunits of the Catalytic 20S Proteasome
Por: Geert Van Gassen, et al.
Publicado em: (1999-10-01)

Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer’s Disease-Associated Presenilin 1 Mutation
Por: Patricia Martín-Maestro, et al.
Publicado em: (2017-09-01)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
Por: Kehoe, P, et al.
Publicado em: (2006)

Galantamine in Alzheimer's disease.
Por: Razay, G, et al.
Publicado em: (2008)

Hyperinsulinaemia and Alzheimer's disease.
Por: Razay, G, et al.
Publicado em: (1994)

Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
Por: Benedikt Kretner, et al.
Publicado em: (2016-03-01)

Age and Alzheimer's disease.
Por: Wilcock, G, et al.
Publicado em: (1983)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
Por: Wilcock, G
Publicado em: (1990)